The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage
ConditionPneumococcal Infections
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-85
SponsorBert Vaes
About this trial
The goal of this cluster-randomized trial is to study the effect of Audit and Feedback loops on pneumococcal vaccination coverage rate in adults at risk in general practice.
The main questions it aims to answer are:
* To assess the effect of "clinical AUDIT and feedback" loops on the pneumococcal vaccination coverage rate in adults at risk in general practice. * To explore whether the increase in vaccination coverage rate after implementation of Audit and Feedback loops is different in specific subgroups (risk groups, male/female, age, smoking status).
Every general practice center assigned to the control or intervention group will have access to a clinical AUDIT to identify patients that may benefit from a pneumococcal vaccination. The general practice centers in the intervention group will also receive an individualized extended electronic feedback report, with multiple components like benchmarked performances and action plans, at baseline and each 2 months from baseline onwards.
Eligibility criteria
Qualifiers
It is a Flemish GP center in the INTEGO network.
The GP center uses an electronic health record (EHR), automatically linked to the INTEGO database.
The physician (one per center, in name of all GPs in that center) signs a specific study consent form.
Adults with an immunity disorder
Disqualifiers
Patients excluded from feedback: patients not belonging to one of the target groups for pneumococcal vaccination.
Patients excluded from AUDIT: patients not belonging to one of the target groups for pneumococcal vaccination OR
Correctly vaccinated high-risk patients (PPV23 less than 5 years ago AND PCV13 ever received)
Correctly vaccinated adults with comorbidity (1) PCV13 ever received AND PPV23 less than 5 years ago, OR 2) PCV13 ever received AND 2x PPV23 vaccination more than 5 years ago)
Trial design
Treatments tested in this trial
- AUDIT and Feedback
Treatment groups
36 Participants
are divided into 2 treatment groupsSponsors and collaborators
Bert Vaes
Lead sponsor
KU Leuven
Sponsor institution
Source ClinicalTrials.gov